Boston Scientific buys stake in Millipede for $90m
Based in Santa Rosa of California, Millipede has developed IRIS transcatheter annuloplasty ring system to treat severe mitral regurgitation (MR). As part of an acquisition option agreement, Boston
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XBased in Santa Rosa of California, Millipede has developed IRIS transcatheter annuloplasty ring system to treat severe mitral regurgitation (MR). As part of an acquisition option agreement, Boston
The study was designed to assess the feasibility and safety of the Tropis ID injector for administering fIPV in a campaign setting. PharmaJet Tropis needle-free injector will deliver vaccines
The legislation suspends until December 2019 the job and innovation destroying 2.3% medical device excise tax imposed on medical device firms. Originally, the tax was set up as
Poland’s Nicolaus Copernicus University research team under the leadership of Ireneusz Grulkowski has worked with Spain-based Universidad de Murcia’s Pablo Artal’s team for the development of the imaging
The company has recruited first patients in the SAVE-US (Surfacer system to facilitate access in venous occlusions – United States) pivotal study. The study will assess the safety
Claimed to be one of the smallest centrifugal pumps in the world, the FloPump 32 is a single use and disposable centrifugal heart pump that can be used
The firms will engage in the development, regulatory support and commercialization of FoundationOne CDx, which is a FDA-approved comprehensive genomic profiling (CGP) assay for all solid tumors that that
Warren and Markey, both Democrats, are from Massachusetts. The bill's re-introduction highlights how many device firms are in Massachusetts. Bot the Democrats are seeking to pay for the repeal by ending
The patented KG 1 graft delivery tool features a cannula, plunger and detachable funnel, which enable easy loading of graft material. Kleiner’s new tool will reduce the costs
The Vectors Post market clinical study will evaluate SCS long-term efficacy and impact on quality of life. The trial will follow patients with chronic intractable pain who are undergoing SCS treatment